In a filing, Organon & Co revealed its Executive Chair COX CARRIE SMITH acquired Company’s shares for reported $0.5 million on Nov 12 ’25. In the deal valued at $7.67 per share,65,400 shares were bought. As a result of this transaction, COX CARRIE SMITH now holds 77,869 shares worth roughly $0.59 million.
Then, COX CARRIE SMITH bought 12,469 shares, generating $100,591 in total proceeds. Upon buying the shares at $8.07, the Director now owns 12,469 shares.
Before that, Falcione Aaron bought 5,500 shares. Organon & Co shares valued at $48,235 were divested by the Chief Human Resources Officer at a price of $8.77 per share. As a result of the transaction, Falcione Aaron now holds 62,974 shares, worth roughly $0.47 million.
Piper Sandler downgraded its Organon & Co [OGN] rating to an Underweight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “an In-line”. JP Morgan also remained covering OGN and has decreased its forecast on September 06, 2024 with a “an Underweight” recommendation from previously “Neutral” rating. Goldman revised its rating on November 03, 2023. It rated OGN as “a Neutral” which previously was an “a Buy”.
Price Performance Review of OGN
On Friday, Organon & Co [NYSE:OGN] saw its stock fall -1.18% to $7.53. Over the last five days, the stock has gained 11.06%. Organon & Co shares have fallen nearly -51.67% since the year began. Nevertheless, the stocks have fallen -49.53% over the past one year. While a 52-week high of $17.23 was reached on 02/13/25, a 52-week low of $6.18 was recorded on 10/30/25.
Levels Of Support And Resistance For OGN Stock
The 24-hour chart illustrates a support level at 7.36, which if violated will result in even more drops to 7.18. On the upside, there is a resistance level at 7.79. A further resistance level may holdings at 8.05.
How much short interest is there in Organon & Co?
A steep rise in short interest was recorded in Organon & Co stocks on 2025-10-31, growing by 0.28 million shares to a total of 13.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 12.82 million shares. There was a rise of 2.17%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 21, 2023 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $28 price target.
